Acacia Pharma Founder Dr. Julian Gilbert steps down – Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession
Cambridge, UK and Indianapolis, US – 18 July 2019: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”, the “Group”), (EURONEXT: ACPH), a pharmaceutical company developing and commercialising hospital products for US and international markets, announces that its founder, Dr Julian Gilbert will step down as Chief Executive Officer and as a Director of the Company on 31 July 2019.
Name: Julian Gilbert
Country: UK
Company: Acacia Pharma Group plc
Branch: Pharma
Position: CEO & Director
Reason: Resigned
Announcement Date: July 17, 2019, 10:00pm
Resignation Date: July 17, 2019, 10:00pm